AREXVY
Total Payments
$10.8M
Transactions
94,768
Doctors
40,368
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $5.2M | 37,571 | 20,489 |
| 2023 | $5.6M | 57,197 | 29,057 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7.5M | 2,560 | 69.0% |
| Food and Beverage | $2.7M | 90,038 | 24.6% |
| Travel and Lodging | $665,310 | 2,041 | 6.2% |
| Space rental or facility fees (teaching hospital only) | $10,900 | 5 | 0.1% |
| Education | $6,783 | 119 | 0.1% |
| Consulting Fee | $2,178 | 5 | 0.0% |
Top Doctors Receiving Payments for AREXVY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Critical Care Medicine | Jackson, MS | $170,436 | 129 |
| , MD | Pulmonary Disease | Eglin Afb, FL | $157,967 | 207 |
| , M.D | Specialist | Summit, NJ | $157,274 | 131 |
| , MD | Pulmonary Disease | Gaffney, SC | $150,781 | 89 |
| , MD | Pulmonary Disease | San Antonio, TX | $150,340 | 142 |
| , M.D | Pulmonary Disease | Fountain Valley, CA | $148,911 | 127 |
| , MD | Pulmonary Disease | Plano, TX | $144,835 | 126 |
| , MD | Sleep Medicine | Royal Oak, MI | $143,329 | 124 |
| , M.D | Critical Care Medicine | Lavonia, GA | $142,747 | 95 |
| , MD | Emergency Medicine | Pittsburgh, PA | $140,467 | 121 |
| , M.D | Internal Medicine | Portland, OR | $134,696 | 134 |
| , M.D | Allergy & Immunology | Vienna, VA | $133,986 | 121 |
| , M.D | Allergy | Charleston, SC | $125,171 | 84 |
| , M.D, MPH | Critical Care Medicine | Fresno, CA | $122,078 | 84 |
| , M.D | Pulmonary Disease | Kailua, HI | $119,426 | 81 |
| , MD | Critical Care Medicine | Phoenix, AZ | $113,558 | 90 |
| , M.D | Pulmonary Disease | Great Neck, NY | $113,430 | 93 |
| , MD | Allergy | Naples, FL | $109,851 | 88 |
| , M.D | Allergy & Immunology | Mission Viejo, CA | $108,962 | 99 |
| , MD | Pulmonary Disease | Rosedale, MD | $108,190 | 75 |
| , MD | Pulmonary Disease | Weston, FL | $108,144 | 55 |
| , M.D | Infectious Disease | South Weymouth, MA | $107,734 | 86 |
| , M.D | Pulmonary Disease | Sugar Land, TX | $107,022 | 50 |
| , M.D | Internal Medicine | Sacramento, CA | $104,819 | 112 |
| , D.O | Internal Medicine | Glastonbury, CT | $102,594 | 96 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $10.8M
Product Information
- Type Drug
- Total Payments $10.8M
- Total Doctors 40,368
- Transactions 94,768
About AREXVY
AREXVY is a drug associated with $10.8M in payments to 40,368 healthcare providers, recorded across 94,768 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2023 to 2024. In 2024, $5.2M was paid across 37,571 transactions to 20,489 doctors.
The most common payment nature for AREXVY is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7.5M, 69.0% of total).